Cargando…

CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth

Aberrant insulin-like growth factor 1 (IGF-1) signaling has been proposed as a contributing factor to the development of neurodegenerative disorders including diabetic neuropathy, and delivery of exogenous IGF-1 has been explored as a treatment for Alzheimer’s disease and amyotrophic lateral scleros...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghanoori, Mohamad-Reza, Agarwal, Prasoon, Gauvin, Evan, Nagalingam, Raghu S., Bonomo, Raiza, Yathindranath, Vinith, Smith, Darrell R., Hai, Yan, Lee, Samantha, Jolivalt, Corinne G., Calcutt, Nigel A., Jones, Meaghan J., Czubryt, Michael P., Miller, Donald W., Dolinsky, Vernon W., Mansuy-Aubert, Virginie, Fernyhough, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930798/
https://www.ncbi.nlm.nih.gov/pubmed/35298717
http://dx.doi.org/10.1007/s00018-022-04201-9
_version_ 1784671116476809216
author Aghanoori, Mohamad-Reza
Agarwal, Prasoon
Gauvin, Evan
Nagalingam, Raghu S.
Bonomo, Raiza
Yathindranath, Vinith
Smith, Darrell R.
Hai, Yan
Lee, Samantha
Jolivalt, Corinne G.
Calcutt, Nigel A.
Jones, Meaghan J.
Czubryt, Michael P.
Miller, Donald W.
Dolinsky, Vernon W.
Mansuy-Aubert, Virginie
Fernyhough, Paul
author_facet Aghanoori, Mohamad-Reza
Agarwal, Prasoon
Gauvin, Evan
Nagalingam, Raghu S.
Bonomo, Raiza
Yathindranath, Vinith
Smith, Darrell R.
Hai, Yan
Lee, Samantha
Jolivalt, Corinne G.
Calcutt, Nigel A.
Jones, Meaghan J.
Czubryt, Michael P.
Miller, Donald W.
Dolinsky, Vernon W.
Mansuy-Aubert, Virginie
Fernyhough, Paul
author_sort Aghanoori, Mohamad-Reza
collection PubMed
description Aberrant insulin-like growth factor 1 (IGF-1) signaling has been proposed as a contributing factor to the development of neurodegenerative disorders including diabetic neuropathy, and delivery of exogenous IGF-1 has been explored as a treatment for Alzheimer’s disease and amyotrophic lateral sclerosis. However, the role of autocrine/paracrine IGF-1 in neuroprotection has not been well established. We therefore used in vitro cell culture systems and animal models of diabetic neuropathy to characterize endogenous IGF-1 in sensory neurons and determine the factors regulating IGF-1 expression and/or affecting neuronal health. Single-cell RNA sequencing (scRNA-Seq) and in situ hybridization analyses revealed high expression of endogenous IGF-1 in non-peptidergic neurons and satellite glial cells (SGCs) of dorsal root ganglia (DRG). Brain cortex and DRG had higher IGF-1 gene expression than sciatic nerve. Bidirectional transport of IGF-1 along sensory nerves was observed. Despite no difference in IGF-1 receptor levels, IGF-1 gene expression was significantly (P < 0.05) reduced in liver and DRG from streptozotocin (STZ)-induced type 1 diabetic rats, Zucker diabetic fatty (ZDF) rats, mice on a high-fat/ high-sugar diet and db/db type 2 diabetic mice. Hyperglycemia suppressed IGF-1 gene expression in cultured DRG neurons and this was reversed by exogenous IGF-1 or the aldose reductase inhibitor sorbinil. Transcription factors, such as NFAT1 and CEBPβ, were also less enriched at the IGF-1 promoter in DRG from diabetic rats vs control rats. CEBPβ overexpression promoted neurite outgrowth and mitochondrial respiration, both of which were blunted by knocking down or blocking IGF-1. Suppression of endogenous IGF-1 in diabetes may contribute to neuropathy and its upregulation at the transcriptional level by CEBPβ can be a promising therapeutic approach. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04201-9.
format Online
Article
Text
id pubmed-8930798
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-89307982022-04-01 CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth Aghanoori, Mohamad-Reza Agarwal, Prasoon Gauvin, Evan Nagalingam, Raghu S. Bonomo, Raiza Yathindranath, Vinith Smith, Darrell R. Hai, Yan Lee, Samantha Jolivalt, Corinne G. Calcutt, Nigel A. Jones, Meaghan J. Czubryt, Michael P. Miller, Donald W. Dolinsky, Vernon W. Mansuy-Aubert, Virginie Fernyhough, Paul Cell Mol Life Sci Original Article Aberrant insulin-like growth factor 1 (IGF-1) signaling has been proposed as a contributing factor to the development of neurodegenerative disorders including diabetic neuropathy, and delivery of exogenous IGF-1 has been explored as a treatment for Alzheimer’s disease and amyotrophic lateral sclerosis. However, the role of autocrine/paracrine IGF-1 in neuroprotection has not been well established. We therefore used in vitro cell culture systems and animal models of diabetic neuropathy to characterize endogenous IGF-1 in sensory neurons and determine the factors regulating IGF-1 expression and/or affecting neuronal health. Single-cell RNA sequencing (scRNA-Seq) and in situ hybridization analyses revealed high expression of endogenous IGF-1 in non-peptidergic neurons and satellite glial cells (SGCs) of dorsal root ganglia (DRG). Brain cortex and DRG had higher IGF-1 gene expression than sciatic nerve. Bidirectional transport of IGF-1 along sensory nerves was observed. Despite no difference in IGF-1 receptor levels, IGF-1 gene expression was significantly (P < 0.05) reduced in liver and DRG from streptozotocin (STZ)-induced type 1 diabetic rats, Zucker diabetic fatty (ZDF) rats, mice on a high-fat/ high-sugar diet and db/db type 2 diabetic mice. Hyperglycemia suppressed IGF-1 gene expression in cultured DRG neurons and this was reversed by exogenous IGF-1 or the aldose reductase inhibitor sorbinil. Transcription factors, such as NFAT1 and CEBPβ, were also less enriched at the IGF-1 promoter in DRG from diabetic rats vs control rats. CEBPβ overexpression promoted neurite outgrowth and mitochondrial respiration, both of which were blunted by knocking down or blocking IGF-1. Suppression of endogenous IGF-1 in diabetes may contribute to neuropathy and its upregulation at the transcriptional level by CEBPβ can be a promising therapeutic approach. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04201-9. Springer International Publishing 2022-03-17 2022 /pmc/articles/PMC8930798/ /pubmed/35298717 http://dx.doi.org/10.1007/s00018-022-04201-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Aghanoori, Mohamad-Reza
Agarwal, Prasoon
Gauvin, Evan
Nagalingam, Raghu S.
Bonomo, Raiza
Yathindranath, Vinith
Smith, Darrell R.
Hai, Yan
Lee, Samantha
Jolivalt, Corinne G.
Calcutt, Nigel A.
Jones, Meaghan J.
Czubryt, Michael P.
Miller, Donald W.
Dolinsky, Vernon W.
Mansuy-Aubert, Virginie
Fernyhough, Paul
CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth
title CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth
title_full CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth
title_fullStr CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth
title_full_unstemmed CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth
title_short CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth
title_sort cebpβ regulation of endogenous igf-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930798/
https://www.ncbi.nlm.nih.gov/pubmed/35298717
http://dx.doi.org/10.1007/s00018-022-04201-9
work_keys_str_mv AT aghanoorimohamadreza cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT agarwalprasoon cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT gauvinevan cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT nagalingamraghus cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT bonomoraiza cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT yathindranathvinith cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT smithdarrellr cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT haiyan cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT leesamantha cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT jolivaltcorinneg cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT calcuttnigela cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT jonesmeaghanj cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT czubrytmichaelp cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT millerdonaldw cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT dolinskyvernonw cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT mansuyaubertvirginie cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth
AT fernyhoughpaul cebpbregulationofendogenousigf1inadultsensoryneuronscanbemobilizedtoovercomediabetesinduceddeficitsinbioenergeticsandaxonaloutgrowth